Renal lithiasis and related diseases

Publications in journals

  • Söhnel, O.; Loucka, T.; Grases, F., "Speciation and supersaturation of urine", "Monatshefte für Chemie", Volume 149, Pages 333-339, 2018. Paper.
  • Grases, F; Costa-Bauza, A; Berga, F; Rodriguez, A; Gomila, R.M; Martorell, G; Martinez-Cignoni, M.R., "Evaluation of inositol phosphates in urine after topical administration of myo-inositol hexaphosphate to female Wistar rats", "Life Sciences", Volume 192, Pages 33-37, 2018. Paper.
  • Barceló, B.; Rodriguez, A.; Ocon Lopez, M.; Costa-Bauza, A.; Gomila, I.; Badal Cogul, M.B.; Grases, F., "Orbitrap¿ high-resolution mass spectrometry for the identification of amoxicillin crystalluria.", "Clinical Chemistry and Laboratory Medicine", Volume 46, Issue 11, Pages 268-271, 2018. Paper.
  • Sanchis, P; Rivera, R.; Berga, F.; Fortuny, R.; Adrover, M.; Costa-Bauza, A.; Grases, F.; Masmiquel, L., "Phytate Decreases Formation of Advanced Glycation End-Products in Patients with Type II Diabetes: Randomized Crossover Trial.", "Scientific Reports", Volume 8, Issue 1, Pages 9619, 2018. Paper.
  • Bauza, J.L.; Pieras, E.C.; Grases, F.; Tubau, V.; Guimerà, J.; Sabaté, X.A., Pizà, P., "Urinary tract infection's etiopathogenic role in nephrolithiasis formation", "Medical Hypotheses", Volume 118, Pages 34-35, 2018. Paper.
  • Costa-Bauzá, A.; Grases, F.; Calvó, P.; Rodriguez, A.; Prieto, R.M., "Effect of consumption of cocoa-derived products on uric acid crystallization in urine of healthy volunteers", "Nutrients", Volume 10, Pages 1516, 2018. Paper.
  • Grases F; Costa-Bauza A; Roig J; Rodriguez A, "Xanthine urolithiasis: Inhibitors of xanthine crystallization.", "Plos One", Volume 13, Issue 8, Pages e0198881, 2018. Paper.
  • Berga F; Luna P; Martorell C; Rey J; Gomila I; Giménez S; Costa-Bauza A; Elorza MA; Sánchez I; Grases F; Barceló B, "2,4-Diamino-N10-methylpteroic acid (DAMPA) crystalluria in a patient with osteosarcoma treated with carboxypeptidase-G2 rescue after high-dose methotrexate-induced nephrotoxicity", "Clinica Chimica Acta", Volume 487, Pages 1-5, 2018. Paper.
  • Adrian Rodriguez; Concepcion Saez-Torres; Concepcion Mir; Paula Casasayas; Nuria Rodriguez; Dolores Rodrigo; Guiem Frontera; Juan Manuel Buades; Cristina Gomez; Antonia Costa-Bauza; Felix Grases, "Effect of sample time on urinary lithogenic risk indexes in healthy and stone-forming adults and children", "Bmc Urology", Volume 18, Pages 116, 2018. Paper.
  • Johnson RJ; Perez-Pozo SE; Lillo JL; Grases F; Schold JD; Kuwabara M; Sato Y; Hernando AA; Garcia G; Jensen T; Rivard C8; Sanchez-Lozada LG; Roncal C; Lanaspa MA., "Fructose increases risk for kidney stones: potential role in metabolic syndrome and heat stress.", "Bmc Urology", Volume 19, Issue 1, Pages 315, 2018. Paper.
  • Perelló, J.; Gómez, M.; Ferrer, M.D.; Rodríguez, N.Y.; Salcedo, C.; Buades, J.M.; Pérez, M.M.; Torregrosa, J.V.; Martín, E.; Maduell, F., "SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels", "Journal of Nephrology", Volume 31, Pages 287, 2018. Paper.
  • Ferrer MD; Ketteler M; Tur F; Tur E; Isern B; Salcedo C; Joubert PH; Behets GJ; Neven E; D'Haese PC; Perelló J., "Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification", "Plos One", Volume 13, Issue 5, Pages e0197061, 2018. Paper.
  • Perelló J; Joubert PH; Ferrer MD; Canals AZ; Sinha S; Salcedo C, "First-Time-In-Human Randomized Clinical Trial in Healthy Volunteers and Haemodialysis Patients with SNF472, a Novel Inhibitor of Vascular Calcification", "British Journal of Clinical Pharmacology", Volume 84, Issue 12, Pages 2867, 2018. Paper.